EPE Special Opportunities Limited Stock
Equities
ESO
BMG3163K1053
Investment Management & Fund Operators
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
176.5 GBX | -.--% | -0.56% | +9.63% |
Apr. 02 | EARNINGS: EPE Special "cautiously optimistic"; RTW Biotech NAV rises | AN |
Mar. 28 | Earnings Flash (ESO.L) EPE SPECIAL OPPORTUNITIES Reports FY24 Loss GBX-1.33 | MT |
Sales 2023 | -39.36M -50.15M | Sales 2024 | 3.75M 4.78M | Capitalization | 49.3M 62.81M |
---|---|---|---|---|---|
Net income 2023 | -43M -54.79M | Net income 2024 | - 0 | EV / Sales 2023 | -1.34 x |
Net Debt 2023 | 2.48M 3.16M | Net cash position 2024 | 2.02M 2.58M | EV / Sales 2024 | 12.6 x |
P/E ratio 2023 |
-1.2
x | P/E ratio 2024 |
-118
x | Employees | - |
Yield 2023 * |
-
| Yield 2024 |
-
| Free-Float | 40.48% |
1 week | -0.56% | ||
1 month | -0.84% | ||
3 months | +8.28% | ||
6 months | +8.62% | ||
Current year | +9.63% |
Managers | Title | Age | Since |
---|---|---|---|
Corporate Secretary | 74 | - |
Members of the board | Title | Age | Since |
---|---|---|---|
David Pirouet
BRD | Director/Board Member | 69 | 19-06-30 |
Clive Spears
CHM | Chairman | 70 | - |
Heather Bestwick
BRD | Director/Board Member | - | 17-02-09 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-31 | 176.5 | -.--% | 0 |
24-05-30 | 176.5 | -.--% | 9,855 |
24-05-29 | 176.5 | -.--% | 0 |
24-05-28 | 176.5 | -0.56% | 1,580 |
24-05-24 | 177.5 | -0.84% | 5,020 |
Delayed Quote London S.E., May 31, 2024 at 11:35 am EDT
More quotes1st Jan change | Capi. | |
---|---|---|
+9.63% | 67.1M | |
+11.58% | 35.72B | |
-0.58% | 34.68B | |
-.--% | 19.82B | |
+4.42% | 5.44B | |
+7.29% | 3.37B | |
+22.64% | 2.96B | |
+9.74% | 2.84B | |
-19.91% | 2.26B | |
+6.53% | 1.26B |
- Stock Market
- Equities
- ESO Stock